TR200003759T2 - Epotilonların biyosentezi için genler - Google Patents

Epotilonların biyosentezi için genler

Info

Publication number
TR200003759T2
TR200003759T2 TR2000/03759T TR200003759T TR200003759T2 TR 200003759 T2 TR200003759 T2 TR 200003759T2 TR 2000/03759 T TR2000/03759 T TR 2000/03759T TR 200003759 T TR200003759 T TR 200003759T TR 200003759 T2 TR200003759 T2 TR 200003759T2
Authority
TR
Turkey
Prior art keywords
epothilone
biosynthesis
genes
epothilons
encodes
Prior art date
Application number
TR2000/03759T
Other languages
English (en)
Turkish (tr)
Inventor
Schupp Thomas
Madison Login James
Molnar Istvan
Zirkle Ross
G�Rlach J�Rn
Cyr Devon
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR200003759T2 publication Critical patent/TR200003759T2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
TR2000/03759T 1998-06-18 1999-06-16 Epotilonların biyosentezi için genler TR200003759T2 (tr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9950498A 1998-06-18 1998-06-18
US10163198P 1998-09-24 1998-09-24
US11890699P 1999-02-05 1999-02-05

Publications (1)

Publication Number Publication Date
TR200003759T2 true TR200003759T2 (tr) 2001-06-21

Family

ID=27378840

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03759T TR200003759T2 (tr) 1998-06-18 1999-06-16 Epotilonların biyosentezi için genler

Country Status (16)

Country Link
EP (1) EP1088078A2 (xx)
JP (3) JP2002518004A (xx)
KR (1) KR100511233B1 (xx)
CN (1) CN100374565C (xx)
AU (1) AU753567B2 (xx)
BR (1) BR9911349A (xx)
CA (1) CA2329774A1 (xx)
HU (1) HUP0102186A3 (xx)
ID (1) ID29128A (xx)
IL (3) IL139735A0 (xx)
NO (2) NO20006195L (xx)
NZ (1) NZ508326A (xx)
PL (1) PL200157B1 (xx)
SK (1) SK19242000A3 (xx)
TR (1) TR200003759T2 (xx)
WO (1) WO1999066028A2 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
FR2775187B1 (fr) 1998-02-25 2003-02-21 Novartis Ag Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo
DE19846493A1 (de) * 1998-10-09 2000-04-13 Biotechnolog Forschung Gmbh DNA-Sequenzen für die enzymatische Synthese von Polyketid- oder Heteropolyketidverbindungen
JP4662635B2 (ja) 1998-11-20 2011-03-30 コーサン バイオサイエンシーズ， インコーポレイテッド エポチロンおよびエポチロン誘導体を生成するための組換え方法および材料
US6410301B1 (en) 1998-11-20 2002-06-25 Kosan Biosciences, Inc. Myxococcus host cells for the production of epothilones
WO2001053533A2 (en) * 2000-01-21 2001-07-26 Kosan Biosciences, Inc. Method for cloning polyketide synthase genes
US6998256B2 (en) 2000-04-28 2006-02-14 Kosan Biosciences, Inc. Methods of obtaining epothilone D using crystallization and /or by the culture of cells in the presence of methyl oleate
ATE309369T1 (de) * 2000-04-28 2005-11-15 Kosan Biosciences Inc Heterologe herstellung von polyketiden
IL155306A0 (en) 2000-10-13 2003-11-23 Univ Mississippi Methods for producing epothilone derivatives and analogs and epothilone derivatives and analogs produced thereby
US7257562B2 (en) 2000-10-13 2007-08-14 Thallion Pharmaceuticals Inc. High throughput method for discovery of gene clusters
SI1483251T1 (sl) 2002-03-12 2010-03-31 Bristol Myers Squibb Co C cian epotilonski derivati
US7767399B2 (en) * 2005-01-31 2010-08-03 Merck & Co., Inc. Purification process for plasmid DNA
DK2668284T3 (en) 2011-01-28 2014-12-15 Amyris Inc Screening of colony micro encapsulated in gel
MX2013013065A (es) 2011-05-13 2013-12-02 Amyris Inc Metodos y composiciones para detectar la produccion microbiana de compuestos inmiscibles em agua.
BR112015002724B1 (pt) 2012-08-07 2022-02-01 Total Marketing Services Método para produzir um composto não catabólico heterólogo, e, composição de fermentação
BR112015023089A2 (pt) 2013-03-15 2017-11-21 Amyris Inc célula hospedeira, método para produzir um isoprenoide, e método para aumentar a produção de acetil-coa ou um composto derivado de acetil-coa
CN105934517A (zh) 2013-08-07 2016-09-07 阿迈瑞斯公司 用于稳定生产乙酰辅酶a衍生化合物的方法
AU2016284689B9 (en) 2015-06-25 2022-01-20 Amyris, Inc. Maltose dependent degrons, maltose-responsive promoters, stabilization constructs, and their use in production of non-catabolic compounds
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
CN111138444B (zh) * 2020-01-08 2022-05-03 山东大学 一组埃博霉素b葡萄糖苷类化合物及其酶法制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753546B2 (en) * 1996-11-18 2002-10-24 Helmholtz-Zentrum Fuer Infektionsforschung Gmbh Epothilone C, D, E and F, production process, and their use as cytostatic as well as phytosanitary agents

Also Published As

Publication number Publication date
IL139735A0 (en) 2002-02-10
HUP0102186A2 (hu) 2001-10-28
KR100511233B1 (ko) 2005-08-31
NZ508326A (en) 2003-10-31
NO20006195L (no) 2001-02-16
IL190391A0 (en) 2008-11-03
WO1999066028A3 (en) 2000-06-29
AU4611699A (en) 2000-01-05
CN100374565C (zh) 2008-03-12
WO1999066028A2 (en) 1999-12-23
CN1305530A (zh) 2001-07-25
PL345579A1 (en) 2001-12-17
NO20091055L (no) 2001-02-16
BR9911349A (pt) 2001-03-13
HUP0102186A3 (en) 2005-10-28
JP2008092958A (ja) 2008-04-24
JP2002518004A (ja) 2002-06-25
ID29128A (id) 2001-08-02
IL139735A (en) 2009-06-15
KR20010052962A (ko) 2001-06-25
CA2329774A1 (en) 1999-12-23
AU753567B2 (en) 2002-10-24
PL200157B1 (pl) 2008-12-31
JP2006061166A (ja) 2006-03-09
SK19242000A3 (sk) 2001-07-10
NO20006195D0 (no) 2000-12-06
EP1088078A2 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
TR200003759T2 (tr) Epotilonların biyosentezi için genler
ATE269402T1 (de) Ikk-beta proteine, nukleinsäuren und verfahren
HUP0001931A2 (hu) Kémiai vegyületek
WO2002020500A3 (en) Materials and methods to potentiate cancer treatment
BRPI0411526A (pt) vìrus de vaccinia e outros microrganismos recombinates modificados e usos dos mesmos
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
EP2289940A3 (en) Treatment of metastatic disease
TR200100074T2 (tr) Nevrotrofik büyüme faktörü
ATE484587T1 (de) Ldcam genannte moleküle
WO2001057058A3 (de) Nachweis von differenzieller genexpression
BR0206852A (pt) Conjugados de polìmero de neublastina e métodos para uso dos mesmos
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
BRPI0409554A (pt) peptacorpo de fusão isolado e recombinante, seqüência de dna, vetor, célula hospedeira, composição farmacêutica e seu uso, kits, método para a produção do peptacorpo de fusão e seqüência de intensificador
CY1108240T1 (el) ΑΠΟΜΟΝΩΜΕΝΑ ΠΟΛΥΝΟΥΚΛΕΟΤΙΔΙΑ ΤΑ ΟΠΟΙΑ ΕΧΟΥΝ ΕΝΑ ΜΕΙΩΜΕΝΟ ΠΕΡΙΕΧΟΜΕΝΟ ΜΟΤΙΒΩΝ 5΄CpG3΄ ΕΠΙΓΕΝΕΤΙΚΟΥ ΕΛΕΓΧΟΥ ΚΑΙ ΟΙ ΧΡΗΣΕΙΣ ΤΟΥΣ
DE69928395D1 (de) Cyclin-e2 proteine und dafür kodierende gene
NO20032818D0 (no) Polypeptider
ATE371022T1 (de) Fy7 polymerase
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
ATE364706T1 (de) Nukleotid- und proteinsequenz von mammastatin und anwendungsmethoden
BR9713248A (pt) Sequência de nucleotìdeos e de proteìnas de mamastatina e processos de uso
WO2003090778A3 (en) Dna vaccine combined with an inducer of tumor cell apoptosis
GB9919766D0 (en) Protein
WO2004071530A3 (en) Identification of cellular polypeptides differentially expressed by tumor cells
BR9912407A (pt) alcool desidrodiconiferìlico éter benzìlicoredutase recombinante e métodos de uso
AU4586800A (en) Chemical compounds